1Life Healthcare, Inc. (NASDAQ:ONEM) has a beta value of 0 and has seen 2,580,767 shares traded in the last trading session. The company, currently valued at $3.75 Billion, closed the last trade at $30 per share which meant it lost -$0.69 on the day or -2.25% during that session. The ONEM stock price is -49.57% off its 52-week high price of $44.87 and 50% above the 52-week low of $15. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.14 Million shares traded. The 3-month trading volume is 1.69 Million shares.
The consensus among analysts is that 1Life Healthcare, Inc. (ONEM) is an Overweight stock at the moment, with a recommendation rating of 2.2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 4 out of 10 have rated it as a Hold, with 6 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.33.
1Life Healthcare, Inc. (NASDAQ:ONEM) trade information
Despite being -2.25% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Wednesday, Aug 05 when the ONEM stock price touched $32.19- or saw a rise of 6.82%. Year-to-date, 1Life Healthcare, Inc. shares have moved 35.93%, while the 5-day performance has seen it change 1.32%. Over the past 30 days, the shares of 1Life Healthcare, Inc. (NASDAQ:ONEM) have changed -20.36%. Short interest in the company has seen 6.65 Million shares shorted with days to cover at 3.93.
Wall Street analysts have a consensus price target for the stock at $33.33, which means that the shares’ value could jump 11.1% from current levels. The projected low price target is $22 while the price target rests at a high of $43. In that case, then, we find that the current price level is +43.33% off the targeted high while a plunge would see the stock lose -26.67% from current levels.
1Life Healthcare, Inc. (ONEM) estimates and forecasts
Earnings growth for 2020 is a modest -18.3% while over the next 5 years, the company’s earnings are expected to increase by 27%.
1Life Healthcare, Inc. (NASDAQ:ONEM)’s Major holders
Insiders own 9.81% of the company shares, while shares held by institutions stand at 67.36% with a share float percentage of 74.69%. Investors are also buoyed by the number of investors in a company, with 1Life Healthcare, Inc. having a total of 69 institutions that hold shares in the company. The top two institutional holders are Carlyle Group Inc. with over 28.16 Million shares worth more than $511.06 Million. As of March 30, 2020, Carlyle Group Inc. held 22.32% of shares outstanding.
The other major institutional holder is FMR, LLC, with the holding of over 9.51 Million shares as of March 30, 2020. The firm’s total holdings are worth over $172.6 Million and represent 7.54% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are BNY Mellon Small/Mid Cap Growth Fd and Fidelity Advisor Growth Opportunities Fund. As of March 30, 2020, the former fund manager holds about 1.06% shares in the company for having 1335349 shares of worth $24.24 Million while later fund manager owns 1.07 Million shares of worth $34.43 Million as of May 30, 2020, which makes it owner of about 0.85% of company’s outstanding stock.